Kaleidoscope logo

Work with external partners
Secure collaboration that saves time
Control permissions
Limit access
Invite guests who only see what is shared with them.
Granular controls
Assign single experiments or give access to entire programs in your workspace. Control exactly what fields are shared, as well as read vs write privileges.
Assign work
Granular sharing
Assign experiments and tasks to guests who only see work assigned to them. Share experiment conditions and relevant entity data if needed (such as compound structure).
Flexible workflows
Guests can upload result files, export an empty spreadsheet to fill out, or input data directly into Kaleidoscope.
Get notified
Real time visibility of work progress and notifications when data becomes available.
State of the art data security
SOC 2 Type 2 certified
Kaleidoscope undergoes rigorous third party SOC 2 audits in accordance with the AICPA's Trust Service Criteria for Security, Confidentiality, and Availability.
FDA 21 CFR Part 11 compliant
Audit ready – this FDA requirement ensures the integrity of electronic records, reducing the risk of data tampering, loss, or unauthorized modifications.
AES-256 bit encryption
Data protected at rest and in transit using AES 256-bit encryption and TLS encryption 1.2 or higher.
Organizations can enable both SAML single sign-on and two-factor authentication as additional options.
The tool of choice for ambitious R&D teams
Kaleidoscope provides the ability to align our key partners, and effectively manage our growing portfolio of IP. It saves us 10 or more hours per week.
Marina Crowe
Chief of Staff
We needed a better system for tracking our R&D data and progress — Kaleidoscope enables more efficient decision making and communication to key stakeholders.
Geraldine Paulus
COO, Co-founder
Kaleidoscope expertly streamlines our data sharing with CROs, making sure Psivant remains in perfect harmony.
Shivam Patel
Head of Data Science & ML
Powerful, intuitive, well-designed ... lets biotechs spend resources on their actual IP: the assets and biology.
Brian Naughton
Co-founder and CTO
We realized that sharing our data in Kaleidoscope was really attractive to Pharma partners – it showed clarity of progress and that we have clean and organized data to work with.
SVP Business Development
Platform Tx company with multi-asset pipeline
Prior to Kaleidoscope it would take me 4-5 steps per workflow to do what I can now achieve in one step. I’m also able to spend 3x less time each week searching for, collating, and navigating data.
Director of Preclinical Operations
Early stage small molecule therapeutics company
Align your team on the big picture